Prostate Cancer Outcomes: International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRonMan)
The Prostate Cancer Outcomes (PCO) International Registry is designed to create an international, population-based registry of 5,000 men with advanced prostate cancer and to describe variations in patient management, experiences, and outcomes in this population. The PCO International Registry will recruit 5,000 patients with advanced prostate cancer internationally, including 500 men with newly diagnosed metastatic hormone sensitive prostate cancer and 4,500 men with M0 and M1 castrate-resistant prostate cancer. Standardised patient-reported outcomes will be collected every 6 months for years 1 and 2, and every 3 months thereafter. Collection of baseline demographics/prior therapies and blood collection will follow informed consent, with follow up data collected for overall survival, skeletal events, hospitalisations, incidence of cardiovascular disease, cancer and acute and chronic diseases, bone scan and imaging.
This information will:
- Inform best treatment practices for patients with advanced disease
- Describe the clinical and molecular subtypes of advanced disease
- Define unmet needs for further study particularly emphasising patient experiences
Investigators
| Ian Vela | APCRC-Q, PAH, IHBI, QUT, TRI |
| Pretoria Bilinski | Greenslopes Private Hospital |
| Geoffrey Coughlin | Royal Brisbane & Women's Hospital, Wesley Hospital and Wesley Urology Clinic |
| Katharine Cuff | PAH |
| James MacKean | Genesis CancerCare QLD |
| Colleen Nelson | APCRC-Q, IHBI, QUT, PAH, TRI |
| David Pryor | APCRC-Q, PAH |
| Christopher Tracey |
Gold Coast Urology, Gold Coast University Hospital, Pindara Private Hospital |
| Euan Walpole | PAH |
| Roger Watson | Mater Hospital and Urology South Brisbane |
| Simon Wood | Greenslopes Urology Clinic |
Duration
Funding
| Movember Foundation |
